Found: 94
Select item for more details and to access through your institution.
Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: "Shadows and Fogs".
- Published in:
- Cancers, 2024, v. 16, n. 16, p. 2877, doi. 10.3390/cancers16162877
- By:
- Publication type:
- Article
Revamping Non-Small Cell Lung Cancer Treatments in Stages II and III: Preparing Healthcare for Cutting-Edge Immuno-Oncology Regimens.
- Published in:
- Cancers, 2024, v. 16, n. 16, p. 2842, doi. 10.3390/cancers16162842
- By:
- Publication type:
- Article
CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study.
- Published in:
- PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0202865
- By:
- Publication type:
- Article
Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb Studies.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.709877
- By:
- Publication type:
- Article
A Network Meta-Analysis of Cancer Immunotherapies Versus Chemotherapy for First-Line Treatment of Patients With Non-Small Cell Lung Cancer and High Programmed Death-Ligand 1 Expression.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.676732
- By:
- Publication type:
- Article
Fears and Perception of the Impact of COVID-19 on Patients With Lung Cancer: A Mono-Institutional Survey.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.584612
- By:
- Publication type:
- Article
Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 16, p. 3951, doi. 10.3390/ijms20163951
- By:
- Publication type:
- Article
Diagnostic and therapeutic issues for patients with advanced non-small cell lung cancer harboring anaplastic lymphoma kinase rearrangement: European vs. US perspective (Review).
- Published in:
- International Journal of Oncology, 2014, v. 45, n. 2, p. 509, doi. 10.3892/ijo.2014.2453
- By:
- Publication type:
- Article
Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer.
- Published in:
- Oncogene, 2003, v. 22, n. 23, p. 3548, doi. 10.1038/sj.onc.1206419
- By:
- Publication type:
- Article
The Evolving Scenario of ES-SCLC Management: From Biology to New Cancer Therapeutics.
- Published in:
- Genes, 2024, v. 15, n. 6, p. 701, doi. 10.3390/genes15060701
- By:
- Publication type:
- Article
Sharing Experience with Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors in Lung Cancer: An Italian Expert Panel Discussion.
- Published in:
- Current Oncology, 2023, v. 30, n. 11, p. 10033, doi. 10.3390/curroncol30110729
- By:
- Publication type:
- Article
Sustained Improvement in the Management of Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocation: Where Are We Running?
- Published in:
- Current Oncology, 2023, v. 30, n. 5, p. 5072, doi. 10.3390/curroncol30050384
- By:
- Publication type:
- Article
Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options.
- Published in:
- Current Oncology, 2023, v. 30, n. 3, p. 3160, doi. 10.3390/curroncol30030239
- By:
- Publication type:
- Article
Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence.
- Published in:
- Current Oncology, 2022, v. 29, n. 1, p. 255, doi. 10.3390/curroncol29010024
- By:
- Publication type:
- Article
Complex Differential Diagnosis between Primary Breast Cancer and Breast Metastasis from EGFR-Mutated Lung Adenocarcinoma: Case Report and Literature Review.
- Published in:
- Current Oncology, 2021, v. 28, n. 5, p. 3384, doi. 10.3390/curroncol28050292
- By:
- Publication type:
- Article
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 2, p. 212, doi. 10.1038/s41416-024-02709-4
- By:
- Publication type:
- Article
New Agents in Advanced Non-Small-Cell Lung Cancer Treatment.
- Published in:
- Oncology, 2009, v. 77, p. 103, doi. 10.1159/000258502
- By:
- Publication type:
- Article
Lung cancer surgery in oligometastatic patients: outcome and survival.
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2020, v. 57, n. 6, p. 1173, doi. 10.1093/ejcts/ezaa005
- By:
- Publication type:
- Article
Induction chemotherapy, extrapleural pneumonectomy and adjuvant radiotherapy for malignant pleural mesothelioma.
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2017, v. 52, n. 5, p. 975, doi. 10.1093/ejcts/ezx122
- By:
- Publication type:
- Article
Evaluation of target coverage and margins adequacy during CyberKnife Lung Optimized Treatment.
- Published in:
- Medical Physics, 2018, v. 45, n. 4, p. 1360, doi. 10.1002/mp.12804
- By:
- Publication type:
- Article
Italian Cohort of Nivolumab Expanded Access Program in Squamous Non‐Small Cell Lung Cancer: Results from a Real‐World Population.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1165, doi. 10.1634/theoncologist.2018-0737
- By:
- Publication type:
- Article
Future Scenarios for the Treatment of Advanced Non-Small Cell Lung Cancer: Focus on Taxane-Containing Regimens.
- Published in:
- Oncologist, 2010, v. 15, n. 10, p. 1102, doi. 10.1634/theoncologist.2010-0322
- By:
- Publication type:
- Article
Clinical Evidence for Second- and Third-Line Treatment Options in Advanced Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2008, v. 13, p. 14, doi. 10.1634/theoncologist.13-S1-14
- By:
- Publication type:
- Article
Clinical Evidence for Second- and Third-Line Treatment Options in Advanced Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2008, v. 13, p. 14, doi. 10.1634/theoncologist.13-S1-14
- By:
- Publication type:
- Article
The Role of Bevacizumab in the Treatment of Non-Small Cell Lung Cancer: Current Indications and Future Developments.
- Published in:
- Oncologist, 2007, v. 12, n. 10, p. 1183, doi. 10.1634/theoncologist.12-10-1183
- By:
- Publication type:
- Article
Reply.
- Published in:
- 2020
- By:
- Publication type:
- letter
Pneumonectomy in Stage IIIA-N2 NSCLC: Should It Be Considered After Neoadjuvant Chemotherapy?
- Published in:
- 2019
- By:
- Publication type:
- journal article
Second-Line Treatment Options in Non-Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Dramatic Antitumor Activity of Nivolumab in Advanced HER2-Positive Lung Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
BEVERLY: Rationale and Design of a Randomized Open-Label Phase III Trial Comparing Bevacizumab Plus Erlotinib Versus Erlotinib Alone as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous Non-Small-Cell Lung Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Stereotactic body radiation therapy for mediastinal lymph node metastases: how do we fly in a 'no-fly zone'?
- Published in:
- Acta Oncologica, 2018, v. 57, n. 11, p. 1532, doi. 10.1080/0284186X.2018.1486040
- By:
- Publication type:
- Article
Avaliação prospectiva de espécimes obtidos por meio de EBUS-TBNA quanto à expressão de programmed death-ligand 1 em pacientes com câncer pulmonar de células não pequenas: um estudo piloto.
- Published in:
- Brazilian Journal of Pulmonology / Jornal Brasileiro de Pneumologia, 2021, v. 47, n. 4, p. 1, doi. 10.36416/1806-3756/e20200584
- By:
- Publication type:
- Article
Overcoming resistance to osimertinib in non-small cell lung cancer: Hopes, doubts, and in-between.
- Published in:
- 2020
- By:
- Publication type:
- editorial
Acquired Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2018, v. 142, n. 4, p. 465, doi. 10.5858/arpa.2017-0158-RA
- By:
- Publication type:
- Article
What Matters Most to Lung Cancer Patients? A Qualitative Study in Italy and Belgium to Investigate Patient Preferences.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.602112
- By:
- Publication type:
- Article
Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies.
- Published in:
- Therapeutic Advances in Medical Oncology, 2014, v. 6, n. 3, p. 101, doi. 10.1177/1758834014521110
- By:
- Publication type:
- Article
Lung Tissue Injury as an Atypical Response to Nivolumab in Non-Small Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 10, p. 1783, doi. 10.1007/s00432-014-1715-2
- By:
- Publication type:
- Article
Results of Multilevel Containment Measures to Better Protect Lung Cancer Patients From COVID-19: The IEO Model.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2020.00665
- By:
- Publication type:
- Article
Patient-Reported Outcomes in Metastatic Nonsquamous Non--Small Cell Lung Cancer: PERLA Trial Comparing First-line Chemotherapy Plus Dostarlimab or Pembrolizumab.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2023, v. 14, n. 11, p. 360
- By:
- Publication type:
- Article
Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42900-4
- By:
- Publication type:
- Article
Real-world treatment patterns for patients receiving second-line and third-line treatment for advanced non-small cell lung cancer: A systematic review of recently published studies.
- Published in:
- PLoS ONE, 2017, v. 12, n. 4, p. 1, doi. 10.1371/journal.pone.0175679
- By:
- Publication type:
- Article
Molecular Testing for Targeted Therapy in Advanced Non-Small Cell Lung Cancer: Suitability of Endobronchial Ultrasound Transbronchial Needle Aspiration.
- Published in:
- 2015
- By:
- Publication type:
- journal article
EGFR-TKI Plus Anti-Angiogenic Drugs in EGFR-Mutated Non–Small Cell Lung Cancer: A Meta-Analysis of Randomized Clinical Trials.
- Published in:
- JNCI Cancer Spectrum, 2020, v. 4, n. 6, p. 1, doi. 10.1093/jncics/pkaa064
- By:
- Publication type:
- Article
Comparison of real-world data (RWD) analysis on efficacy and post-progression outcomes with pembrolizumab plus chemo vs chemo alone in metastatic non-squamous non-small cell lung cancer with PD-L1 < 50%.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.980765
- By:
- Publication type:
- Article
Long-term clinical outcomes and prognostic factors of upfront surgery as a first-line therapy in biopsy-proven clinical N2 non-small cell lung cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.933278
- By:
- Publication type:
- Article
Incorporating atezolizumab in the adjuvant setting of non-small cell lung cancer: key discussion points from an expert multidisciplinary panel by Italian Association of Thoracic Oncology.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.971042
- By:
- Publication type:
- Article